Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Wehrli

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Current Opinion in Pharmacology|July 1, 2021
New CARs on and off the road: challenges and new developments in CAR-T cell therapyMarc Wehrli, Marcela V Maus
Praxis|April 24, 2014
[Primary immune thrombocytopenia]Marc Wehrli, Jeroen S Goede
Annual Review of Medicine|August 11, 2020
Toward Better Understanding and Management of CAR-T Cell-Associated ToxicityAndrea Schmidts, Marc Wehrli, Marcela V Maus
Seminars in Hematology|May 14, 2013
Cell death in immune thrombocytopenia: novel insights and perspectivesStephan von Gunten, Marc Wehrli, Hans-Uwe Simon
Immunological Reviews|September 11, 2023
"Hurdles race for CAR T-cell therapy in digestive tract cancer"Marie-Noelle Kronig, Marc Wehrli, Diego Salas-Benito, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2017
Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal FluidChristoph Schneider, Marlies Illi, Marius Lötscher, et al.
Immunobiology|April 6, 2010
Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wallFabian Blank, Marc Wehrli, Andrea Lehmann, et al.
The Oncologist|March 1, 2017
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and <i>CEP110</i>-<i>FGFR1</i> RearrangementMarc Wehrli, Elisabeth Oppliger Leibundgut, Heinrich H Gattiker, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2018
Histology of Nivolumab-Induced ThyroiditisChristina Neppl, Reto M Kaderli, Roman Trepp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironmentMarc Wehrli, Fabiola Cortinas-Elizondo, Ruslan Hlushchuk, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Current Opinion in Pharmacology|July 1, 2021
New CARs on and off the road: challenges and new developments in CAR-T cell therapyMarc Wehrli, Marcela V Maus
Praxis|April 24, 2014
[Primary immune thrombocytopenia]Marc Wehrli, Jeroen S Goede
Annual Review of Medicine|August 11, 2020
Toward Better Understanding and Management of CAR-T Cell-Associated ToxicityAndrea Schmidts, Marc Wehrli, Marcela V Maus
Seminars in Hematology|May 14, 2013
Cell death in immune thrombocytopenia: novel insights and perspectivesStephan von Gunten, Marc Wehrli, Hans-Uwe Simon
Immunological Reviews|September 11, 2023
"Hurdles race for CAR T-cell therapy in digestive tract cancer"Marie-Noelle Kronig, Marc Wehrli, Diego Salas-Benito, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 2, 2017
Isolation of Antibodies from Human Plasma, Saliva, Breast Milk, and Gastrointestinal FluidChristoph Schneider, Marlies Illi, Marius Lötscher, et al.
Immunobiology|April 6, 2010
Macrophages and dendritic cells express tight junction proteins and exchange particles in an in vitro model of the human airway wallFabian Blank, Marc Wehrli, Andrea Lehmann, et al.
The Oncologist|March 1, 2017
Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and <i>CEP110</i>-<i>FGFR1</i> RearrangementMarc Wehrli, Elisabeth Oppliger Leibundgut, Heinrich H Gattiker, et al.
Thyroid : Official Journal of the American Thyroid Association|October 16, 2018
Histology of Nivolumab-Induced ThyroiditisChristina Neppl, Reto M Kaderli, Roman Trepp, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 24, 2014
Human IgA Fc receptor FcαRI (CD89) triggers different forms of neutrophil death depending on the inflammatory microenvironmentMarc Wehrli, Fabiola Cortinas-Elizondo, Ruslan Hlushchuk, et al.
Pageof 3